Discussion
Hepatic hemangioma is a benign vascular tumor. It is the second most common liver tumor after hepatoblastoma of the fetal, neonatal, and childhood period of life, and accounts for 12% of pediatric hepatic tumors [1-6]. Its pathogenesis is poorly known. 20% of cases are accompanied with cutaneous and visceral lesions [7]. Hemangioma may grow in size during the first six months of life following by spontaneous regression. The growth phase may be associated with heart failure due to hyperkinetic circulation, Kasabach–Merritt syndrome, jaundice, or very rarely hepatocellular insufficiency [8].
References
1. Mueller BU, Mulliken JB. The infant with a vascular tumor. Semin Perinatol 1999; 23: 332–40
2. Mejides AA, Adra AM, O’Sullivan MJ, Nicholas MC. Prenatal diagnosis and therapy for a fetal hepatic vascular malformation. Obstet Gynecol 1995; 85: 850–3
3. Abuhamad AZ, Lewis D, Inati MN, Johnson DR, Copel JA. The use of color flow Doppler in the diagnosis of fetal hepatic hemangioma.J Ultrasound Med 1993; 4: 223-6
4. Sepúlveda WH, Donetch G, Giuliano A. Prenatal sonographic diagnosis of hepatic hemangioma. Eur J Obstet Gynecol Reprod Biol 1993; 48: 73–6
5. Helmberger TK, Ros PR, Mergo PJ et al. Pedriatric liver neoplasms: A radiologic-pathologic correlation. Eur Radiol 1999; 9: 1339– 1347
6. Schweinitz Dvon . Neonatal liver tumors. Seminars in Neonatology 2003; 8: 403– 10
7. Schmitz R, Heinig J, Klockenbusch W, Kiesel L, Steinhard J,Antenatal Diagnosis of a Giant. Fetal Hepatic Hemangioma and Treatment with Maternal Corticosteroid Ultraschall in Med 2009; 30
8. S.Franchi-Abella, D. Pariente. Tumeurs hépatique de l'enfant: approche par l'imagerie; EMC radiodiagnostic-appareil digestif 2005.